Sang Min Lee1, Minha Hong2, Saengryeol Park3, Won Sub Kang1, In-Hwan Oh4. 1. Department of Psychiatry, Kyung Hee University Hospital, Kyung Hee University College of Medicine, 1 Hoegi-Dong, Dongdaemug-Gu, Seoul, 130-701, South Korea. 2. Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine, 55 Hwasu-ro 14 beon-gil, Deogyang-gu, Goyang, 10475, South Korea. 3. Department of Physical Education, College of Education, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, South Korea. 4. Department of Preventive Medicine, Kyung Hee University School of Medicine, 1 Hoegi-Dong, Dongdaemug-Gu, Seoul, 130-701, South Korea. parenchyme@gmail.com.
Abstract
BACKGROUND: Few studies have investigated the epidemiology of eating disorders using national representative data. In this study, we investigated the treatment prevalence and economic burden of eating disorders in South Korea. METHODS: The aim of this study was to estimate the treatment prevalence and the medical expenditure of diagnosed eating disorders (ICD F50.x) in South Korea between 2010 and 2015. We also examined the economic costs of eating disorders, including the direct medical cost, direct non-medical costs, and indirect costs, in order to calculate the economic burden of such disorders. RESULTS: The total treatment prevalence of eating disorders in South Korea was 12.02 people (per 100,000) in 2010, and 13.28 in 2015. The cost of medical expenditures due to eating disorders increased from USD 1229724 in 2010 to USD 1843706 in 2015. The total economic cost of eating disorders was USD 5455626 in 2015. In 2015, the economic cost and prevalence of eating disorders was the highest in the 20-29 age group. CONCLUSIONS: The results showed the eating disorders are insufficiently managed in the medical insurance system. Further research is therefore warranted to better understand the economic burdens of each type of eating disorder.
BACKGROUND: Few studies have investigated the epidemiology of eating disorders using national representative data. In this study, we investigated the treatment prevalence and economic burden of eating disorders in South Korea. METHODS: The aim of this study was to estimate the treatment prevalence and the medical expenditure of diagnosed eating disorders (ICD F50.x) in South Korea between 2010 and 2015. We also examined the economic costs of eating disorders, including the direct medical cost, direct non-medical costs, and indirect costs, in order to calculate the economic burden of such disorders. RESULTS: The total treatment prevalence of eating disorders in South Korea was 12.02 people (per 100,000) in 2010, and 13.28 in 2015. The cost of medical expenditures due to eating disorders increased from USD 1229724 in 2010 to USD 1843706 in 2015. The total economic cost of eating disorders was USD 5455626 in 2015. In 2015, the economic cost and prevalence of eating disorders was the highest in the 20-29 age group. CONCLUSIONS: The results showed the eating disorders are insufficiently managed in the medical insurance system. Further research is therefore warranted to better understand the economic burdens of each type of eating disorder.
Authors: Anders Gustavsson; Mikael Svensson; Frank Jacobi; Christer Allgulander; Jordi Alonso; Ettore Beghi; Richard Dodel; Mattias Ekman; Carlo Faravelli; Laura Fratiglioni; Brenda Gannon; David Hilton Jones; Poul Jennum; Albena Jordanova; Linus Jönsson; Korinna Karampampa; Martin Knapp; Gisela Kobelt; Tobias Kurth; Roselind Lieb; Mattias Linde; Christina Ljungcrantz; Andreas Maercker; Beatrice Melin; Massimo Moscarelli; Amir Musayev; Fiona Norwood; Martin Preisig; Maura Pugliatti; Juergen Rehm; Luis Salvador-Carulla; Brigitte Schlehofer; Roland Simon; Hans-Christoph Steinhausen; Lars Jacob Stovner; Jean-Michel Vallat; Peter Van den Bergh; Peter Van den Bergh; Jim van Os; Pieter Vos; Weili Xu; Hans-Ulrich Wittchen; Bengt Jönsson; Jes Olesen Journal: Eur Neuropsychopharmacol Date: 2011-09-15 Impact factor: 4.600
Authors: Ronald C Kessler; Patricia A Berglund; Wai Tat Chiu; Anne C Deitz; James I Hudson; Victoria Shahly; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Corina Benjet; Ronny Bruffaerts; Giovanni de Girolamo; Ron de Graaf; Josep Maria Haro; Viviane Kovess-Masfety; Siobhan O'Neill; Jose Posada-Villa; Carmen Sasu; Kate Scott; Maria Carmen Viana; Miguel Xavier Journal: Biol Psychiatry Date: 2013-01-03 Impact factor: 13.382
Authors: Debra L Franko; Aparna Keshaviah; Kamryn T Eddy; Meera Krishna; Martha C Davis; Pamela K Keel; David B Herzog Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112